References
1. Park, K.-S. et al., (2006) Am J Respir Cell Mol Biol. 34:151–157. 2. Akeno N., et al. 2014. Oncogene. 2014 Jan 27. doi: 10.1038/onc.2013.589. [Epub ahead of print].|Other references:|1. Adams, R.R., et al., J. Cell Biol. 153: 865-880 (2001). 2. Canela, N., et al., J. Biol. Chem. 278: 1158-1164 (2003). 3. Seigel, P.M. et al., Proc Natl. Acad. Sci. USA 100: 8430-8435 (2003). 4. Wei, Y., et al., Cell 97: 99-109 (1999) 5. Miller, L.D., et al., Developmental Dynamics 231: 57-71 (2004). 6. Chadee, D.N., et al., J. Biol. Chem. 270: 20,098-20,105 (1995). 7. Ajiro, K., et al., J. Biol. Chem. 271: 13,197-13,201 (1996). 8. Mahadevan, L.C., et al., Cell 65: 775-783 (1991). 9. Hendzel, M.J., et al., Chromasoma 106: 348-360 (1997).USBio References
US Biological application reference: Park, K.-S. et al., (2006) Am J Respir Cell Mol Biol. 34:151–157. 2. Akeno N., et al. 2014. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene. 2014 Jan 27. doi: 10.1038/onc.2013.589. [Epub ahead of print].